Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity
| Image |  |
|---|---|
| Description | scientific article published on April 2007 |
| Author/s |
author: Syed-Rehan A Hussain Carolyn Cheney Michael R Grever Thomas Lin Pedersen John C. Byrd Michael A Caligiuri |
| Publication date | April 1, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |